Abstract：【Objective】To explore the clinical effect of transcutaneous nerve electrical stimulation in the treatment of fatigue caused by chemotherapy for cervical cancer. 【Methods】From February 2016 to December 2018, 82 patients who received postoperative chemotherapy for cervical cancer in our hospital were divided into observation group and control group, 41 cases in each group. The control group was given routine nursing, and the observation group was treated with transcutaneous nerve electrical stimulation twice a week for six weeks. The fatigue of the patients in the two groups was assessed by MFI and FQ, and the mood of the patients in the two groups was assessed by HADS. 【Results】Before treatment, there was no significant difference in MFI score, FQ score and hads score between the two groups (P>0.05); after 6 weeks of intervention, the MFI score, FQ score and hads score of the observation group were significantly lower than that before treatment (P<0.05), and the MFI score, FQ score and HADS score of the control group were no significant change compared with that before treatment (P>0.05); moreover, each index of the observation group was significantly lower than that of the control group The difference was statistically significant (P<0.05). 【Conclusion】Transcutaneous nerve electrical stimulation can improve the fatigue of patients with cervical cancer caused by chemotherapy, and relieve the anxiety and depression of patients, which is worthy of clinical application.
[1] Kurimoto R,Takiguchi Y.Monitoring the side effects of cancer chemotherapy[J].Nihon Rinsho,2015, 73(Suppl 2):102. [2] Wang K,Qi S,Lai H,et al.Clinical massage therapy for patients with cancer-related fatigue protocol of a systematic review[J].Medicine,2018,97(49):e13440. [3] Lee YH,Lai GM,Lee DC,et al.Promoting physical and psychological rehabilitation activities and evaluating potential links among cancer-related fatigue, fear of recurrence, quality of life, and physiological indicators in cancer survivors[J].Integr Cancer Ther,2018,17(4):1183-1194. [4] Starreveld DEJ,Daniels LA,Valdimarsdottir HB,et al.Light therapy as a treatment of cancer-related fatigue in (non-)Hodgkin lymphoma survivors (SPARKLE trial): study protocol of a multicenter randomized controlled trial[J].BMC Cancer,2018,18(1):880. [5] Ferentinos P, Kontaxakis VKB, Dikeos D, et al. The fatigue questionnaire: standardization in patients with major depression[J].Psychiatry Res,2010, 177(1):114-119. [6] Nezlek J B, Rusanowska M, Holas P, et al. The factor structure of a Polish language version of the hospital anxiety depression scale (HADS)[J].Curr Psychol,2019, 17(4):1-9. [7] Chen W, Zheng R, Baade P D, et al. Cancer statistics in China, 2015[J].CA Cancer J Clin,2016, 66(2):115-132. [8] Suzuki K,Kobayashi N,Ogasawara Y,et al.Clinical significance of cancer-related fatigue in multiple myeloma patients[J].Int J Hematol,2018,108(6):580-587. [9] Lacourt TE,De La Garza R.Can cancer-related cognitive impairment be considered in isolation from other cancer-related symptoms[J] Psychooncology,2018,27(10):2511-2512. [10] Tamada S,Ebisu K,Yasuda S,et al.Kamikihito improves cancer-related fatigue by restoring balance between the sympathetic and parasympathetic nervous systems[J].Prostate Int,2018,6(2):55-60.
2019, Vol. 36 
